Verona Pharma plc - Special Call Transcript
Hello, ladies and gentlemen, and welcome to Verona Pharma's Phase IIb Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to turn the call over to Kimberly Minarovich, Managing Director of Argot Partners.
Thank you, operator. Hello, ladies and gentlemen, and welcome to Verona Pharma's Phase II Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to review Verona Pharma's 4-week Phase II clinical trial data of nebulized ensifentrine on top line -- on top of tiotropium therapy for COPD.
With me today are Jan-Anders Karlsson, Chief Executive Officer; and Piers Morgan, Chief Financial Officer. Earlier today, we issued a press release detailing these top line clinical trial results. A copy of the release can be found in the Investor Relations section of our corporate website at www.veronapharma.com.
On today's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
